Tag: CNDO

Blue Horseshoe Stocks: CNDO Recap & Much More

Esperion Therapeutics, Inc. ESPR

ESPR was an unstoppable juggernaut for us this week. On Tuesday, we floated the idea of tracking the ESPR 04/17 $90 Calls, and those contracts have gone on a wild run since then.

As the stock pushed its way to new 52-week highs yesterday, finally topped those contracts out at 28.50, it marked an overall increase of 714% from the 3.50 low we observed on Tuesday; quite an impressive feat for a span of just three sessions.

Add in the multiplicity of opportunities in short-term weekly calls that we’ve witnessed (on the order of percentage gains in the thousands!) as the stock made this historical run, and we’ll have to mark ESPR down as one of our most successful alerts thus far in 2015.

Coronado BioSciences, Inc. CNDO

CNDO did quite well following our tag of it in yesterday morning’s extended watchlist, further solidifying the notion that biopharmas have been on a real hot streak this week.

We watched as CNDO ripped its way from a daily low of 3.62 to as high as 5.35, totaling an intraday run of 48% The move came on volume which smashed the 3-month average by a factor of more than 32X Congrats to any of our readers who lassoed this momentum-mover for some tidy gains yesterday!

Amicus Therapeutics, Inc. FOLD

FOLD also appear on yesterday’s watchlist before extending its own epic run with a modest yet notable increase of 13% on the day, trading a range from 11.63-13.20. Like the previously mentioned play, this stock has also been on a blue-sky breakout, setting new annual highs with every uptick.

Morning Gappers – Options Ideas

Nike, Inc. NKE shares surged as the company beat Wall St. estimates for profits on yesterday’s earnings call, and appears to be gapping up significantly in this morning’s premaket activity. We are going to be monitoring the $101-104 Weekly Calls for potential daytrading opportunities, and for a possible a swing trade into the weeks ahead, we’ll radar the 04/10 $105-110 Calls.

Prothena Corp plc PRTA is gapping up monstrously today to the tune of 40%, soaring on yesterday’s post-market revelation of positive Phase 1 results for its treatment for Parkinson’s disease. We will be placing $35 and 40 Calls on watch for daytrading potential, while tracking the 06/19 $45 Calls for a longer-term play.

Extended Watchlist:
VBLT, SPEX, VGGL, ICLD, RNN

Blue Horseshoe Stocks: ESPR Options, MVIS Recaps & More


Esperion Therapeutics, Inc. ESPR

ESPR found new highs once again yesterday for the second straight session after we initially tagged it for options trading potential on Tuesday.

In addition to monitoring Weekly In-the-money Calls, which yielded up the opportunity at gains ranging from 400-1400% on Tuesday, and continued their own runs yesterday, we also had specified a longer-term idea that continued to work extraordinarily well.

That idea, the 04/17 $90 Calls, traded from a low of 11.60 all the way up to 21.90 yesterday. It represented an excellent single-session intraday increase of 89%, and a whopping 525% jump over our observed low from Tuesday (3.50).

Big congratulations go out to any of our readers who reaped the benefits ESPR, which has easily emerged as our top target of the week! The stock is gapping up in the premarket this morning, so it appears as if we could see a further extension of those gains.

Microvision, Inc. MVIS

On Monday we tagged MVIS in a gap-up watchlist, and it has found its way into every one of our reports this week, setting new highs each day.

Yesterday the stock traded in a range from 3.42-4.23, a healthy intraday move of 24% From our observed low of 2.88 on Monday, that high marked a rise of 47% overall.

As you can see below, given the extremely over-bought look of the chart, now might be a good time to lock in any profits gained over the course of the week. This major move has been fueled by a PR out Monday in which the company announced orders totaling more than $14M it had received for components of its patented PicoP® display technology >> VIEW PR

Side Note:

Yesterday in advance of the FOMC Meeting, we cautioned readers to stay alert and watch for the effect that Janet Yellen’s commentary would have on the markets. To take advantage of this expected surge in either direction, we mentioned trading options calls on either the SPY, if the markets went up, or UVXY and/or VIX if they slid back.  Either way it played out, we said, we wanted “to stay in-the-money with our strike prices.”

As it turned out, the Fed announcement caused a sharp rise in the markets, and as a result the SPY Calls were the ones to play. We saw substantial gains on in-the-money Calls as the SPY spiked to $211.27.

For example, the SPY $209.50 Calls traded in a range from .80-2.00, for an intraday move totaling 150%  $210 Calls also spiked heavily from a low of .40 to as much as 1.59, a huge 297% jump.

Extended Watchlist:
FOLD, RAD, NQ, CNDO, SYN, SMLR

Blue Horseshoe Stocks: Pharma Watchlist & More

Lexicon Pharmaceuticals, Inc. LXRX

We’re taking notice of LXRX this morning in the wake of a premarket PR that has the stock trending up to its highest levels of the past three months; it contained updates on current projects as well as increased earnings. The addition of an interesting setup on the chart gives us good reason to place LXRX on watch this mid-week.

As you can see on the snapshot below, the stock gapped down significantly at the end of November. In premarket activity today we’re seeing a partial fill taking place. We’re going to be watching for LXRX to fill the remainder of the gap into the mid 1.20’s where its next area of resistance will come in at the 200DMA of 1.28.

THE WOODLANDS, Texas, March 4, 2015 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.>> VIEW PR

Pharmaceutical Watchlist

There are a number of other pharma and biopharma stocks gapping up in the premarket this morning, some of which have appeared in our reports in the past. We’ve listed them below along with links to today’s news, where applicable:

Keryx Biopharmaceuticals, Inc. KERX


Atossa Genetics, Inc. ATOS


Coronado Biosciences, Inc. CNDO

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies (Wed 8:30AM EST)

PhotoMedex, Inc. PHMD

Orexigen Therapeutics, Inc. OREX

KaloBios Pharmaceuticals, Inc. KBIO

Earnings-Related Options Ideas

American Eagle Outfitters, Inc. AEO beat expected Q4 profits and revenues, and is gapping up as a result. To take advantage of the trend, we are monitoring options trading possibilities in the AEO Weekly $15-16 Calls

Abercrombie & Fitch ANF fell short of expectations with regard to sales, which is fueling a downtrend here in the premarket, so we’ll take the opposite approach here, and keep an eye on ANF Weekly $23-24 Puts.

Extended Watchlist:
IFON, PLUG, NPTN, WLT, LEI

CNDO, FREE, WPCS & Extended Watchlist

Coronado Biosciences, Inc. CNDO

When we last visited CNDO, we made mention of the large gap on the chart that we were looking to see filled. At the time (Dec.12th), we observed prices as low as 1.75. Now two weeks later, we have seen some real strides toward the filling of that gap, with yesterday’s high of 3.09 marking a gain of 77%

The stock has been making higher lows for the past four sessions, and we’ve mentioned that a break of the 50DMA could lead to further gains. Now that it has happened, we are going to be extra vigilant over this play.

We took the liberty of drawing up a video chart on CNDO for your convenience:

As far as options trading is concerned, we are currently eyeballing the 01/18/14 2.50 Calls, which closed at .72 yesterday. A return of the stock to previous levels in the $4-5 range would likely yield multi-bag gains on those contracts.

FreeSeas, Inc. FREE

FREE has been a big winner for us in the recent past. Following our last alert, the stock was trading as low as 1.12. We had previously ridden FREE for gains of more than 400% and after watching it consolidate heavily, we mentioned that chart indicators were signaling the beginning of what we assumed would be another significant run.

Once again, our assumptions proved to be highly accurate. The stock has found its way off its bottom, yesterday reaching as high as 2.40. That marks an opportunity for gains on the order of 114% in just a couple of weeks.

WPCS International, Inc. WPCS

On December 23rd, WPCS appeared in our extended watchlist. It didn’t take long to see a positive move out of this stock; yesterday as it traded from a low of 1.46 to 1.619, it afforded traders the chance at a modest 11% gain.

We really want to keep an eye out for further movement on WPCS, as the stock is gapping up heavily this morning, to the tune of roughly 80% This comes on the heels of yesterday’s news that the company has developed a Bitcoin trading platform to capitalize on the recent digital currency fad.

EXTON, PA, Dec 26, 2013 (Marketwired via COMTEX) — WPCS International Incorporated (NASDAQ: WPCS), (“WPCS” or the “Company”), today announced that its wholly-owned subsidiary, BTX Trader, LLC (“BTX Trader” or “BTX”) has released a beta version of its Windows-based trading platform that is now available to the public at www.btxtrader.com. BTX Trader, which was recently acquired by WPCS, is the first trading platform to enable Bitcoin traders and industry researchers to access market data and execute orders on the five most popular Bitcoin exchanges in a single application.

Extended Watchlist:
PROW, DRYS, GNK, NEWL, EGLE, RSOL, SHIP

Blue Horseshoe: The Week in Review

For as long as we can remember following the Penny Stock Rumble, we can’t recall a time when a newsletter took the top spot on 3 out of 4 days, but with yesterday’s session, we did in fact reach that difficult achievement! We were anticipating our first ever hat-trick, and we were not disappointed. The following video outlines some of this week’s biggest successes:

Tiger Oil & Energy, Inc. TGRO

We started off Monday with TGRO, which traded as low as .36, and hit .635 on Tuesday for a 76% gain. It would then dip back to .38 before reversing again and surging as high as .62 yesterday for up to 63% on the rebound.

That brought this week’s cumulative gains from TGRO to a total of 139%.

BG Medicine, Inc. BGMD

Next came BGMD, which we spotted on Tuesday trading as low as .6115. We would witness this play running to a high of 1.70 by Wednesday, giving us the opportunity at 178% in possible gains.

CytRx Corp. CYTR

Last but not least, was Wednesday’s alert of CYTR, which looks like it could sprout legs again today. CYTR was as low as 3.45 at the time of our initial alert, and hit a high of 6.36 yesterday, racking in 84% in gains!

This morning, CYTR is gapping up once again, trading in the 6.55 range; if the breakout continues, consider it another triple-digit winner for us.

This was the play that gave us our third winning appearance on the Rumble:

Coronado BioSciences, Inc. CNDO

CNDO jumped out at us as a stock with a serious gap to fill on the chart. As you can see below, back in October the stock fell off a cliff from the $6-8 range all the way down to present levels.

This is a potential play that we’ll want to monitor closely moving forward, because a break of the 50DMA could very well lead to the filling of at least a portion of that gap, a move which would carry with it some significant gains.

With calls like these this week, we’ve made other newsletters obsolete! Nowhere else can you find both diversification into many areas of finance(from microcaps, to big-boards, to options-trading & more), and winning picks on such a consistent basis. Why would you go anywhere else? The word ‘quit’ is not in our vocabulary, which is why we’ll come back time and time again, providing our readers with the highest-quality picks available! We’re wrapping up another hugely successful week, so be sure to get back with us on Monday when we’ll do it all over again!

Extended Watchlist:
SFBR, PLUG, MACK, CLSN, ICLD, PVG, PTIX, ETAK

Get Our FREE Daily Reports!

SUBSCRIBE